Inventor
MAK CHI CHING
US35 patents
⚠️ This page may combine multiple inventors who share the name “MAK CHI CHING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SAMUMED LLC
16 patentsUS9745271B2Aug 29, 2017
5-substituted indazole-3-carboxamides and preparation and use thereof
SAMUMED LLC58 citations97
US9951048B1Apr 24, 2018
Isoquinolin-3-yl carboxamides and preparation and use thereof
SAMUMED LLC13 citations92
US10947217B2Mar 16, 2021
Isoquinolin-3-YL carboxamides and preparation and use thereof
SAMUMED LLC4 citations84
US10100038B2Oct 16, 2018
Isoquinolin-3-yl carboxamides and preparation and use thereof
SAMUMED LLC3 citations84
US10287267B2May 14, 2019
Isoquinolin-3-yl carboxamides and preparation and use thereof
SAMUMED LLC7 citations83
US10544128B2Jan 28, 2020
Isoquinolin-3-yl carboxamides and preparation and use thereof
SAMUMED LLC2 citations73
US10106527B2Oct 23, 2018
Isoquinolin-3-yl carboxamides and preparation and use thereof
SAMUMED LLC3 citations73
US10556885B2Feb 11, 2020
Isoquinolin-3-YL carboxamides and preparation and use thereof
SAMUMED LLC1 citations72
US10508099B2Dec 17, 2019
Isoquinolin-3-yl carboxamides and preparation and use thereof
SAMUMED LLC1 citations72
US10934297B2Mar 2, 2021
5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof
SAMUMED LLC1 citations62
US10604514B2Mar 31, 2020
6-(5-membered heteroaryl)isoquinolin-3-yl carboxamides and preparation and use thereof
SAMUMED LLC1 citations62
US10744128B2Aug 18, 2020
6-(5-membered heteroaryl)isoquinolin-3-yl-(5-membered heteroaryl) carboxamides and preparation and use thereof
SAMUMED LLC0 citations52
US10413537B2Sep 17, 2019
6-(5-membered heteroaryl)isoquinolin-3-yl-(5-membered heteroaryl) carboxamides and preparation and use thereof
SAMUMED LLC0 citations52
US10669240B2Jun 2, 2020
5-substituted indazole-3-carboxamides and preparation and use thereof
SAMUMED LLC0 citations51
US10703748B2Jul 7, 2020
Diazanaphthalen-3-yl carboxamides and preparation and use thereof
SAMUMED LLC0 citations41
US10653688B2May 19, 2020
6-(6-membered heteroaryl and aryl)isoquinolin-3-yl carboxamides and preparation and use thereof
SAMUMED LLC0 citations41
BIOSPLICE THERAPEUTICS INC
6 patentsUS11673881B2Jun 13, 2023
Isoquinolin-3-yl carboxamides and preparation and use thereof
BIOSPLICE THERAPEUTICS INC1 citations72
US11548872B2Jan 10, 2023
Isoquinolin-3-yl carboxamides and preparation and use thereof
BIOSPLICE THERAPEUTICS INC2 citations72
US11174244B2Nov 16, 2021
Isoquinolin-3-yl carboxamides and preparation and use thereof
BIOSPLICE THERAPEUTICS INC3 citations72
US12281097B2Apr 22, 2025
Isoquinolin-3-yl carboxamides and preparation and use thereof
BIOSPLICE THERAPEUTICS INC0 citations62
US11713320B2Aug 1, 2023
5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof
BIOSPLICE THERAPEUTICS INC0 citations62
US12134625B2Nov 5, 2024
Pyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof
BIOSPLICE THERAPEUTICS INC0 citations48
TARGEGEN INC
5 patentsUS7528143B2May 5, 2009
Bi-aryl meta-pyrimidine inhibitors of kinases
TARGEGEN INC220 citations98
US7825246B2Nov 2, 2010
Bi-aryl meta-pyrimidine inhibitors of kinases
TARGEGEN INC40 citations91
US8030487B2Oct 4, 2011
2-amino—5-substituted pyrimidine inhibitors
TARGEGEN INC10 citations82
US7691858B2Apr 6, 2010
Kinase inhibitors and methods of use thereof
TARGEGEN INC11 citations82
US7456176B2Nov 25, 2008
Benzotriazine inhibitors of kinases
TARGEGEN INC11 citations81
DART NEUROSCIENCE CAYMAN LTD
3 patentsUS9150572B2Oct 6, 2015
Substituted naphthyridine and quinoline compounds as MAO inhibitors
DART NEUROSCIENCE CAYMAN LTD2 citations61
US9102674B2Aug 11, 2015
Substituted naphthyridine and quinoline compounds as MAO inhibitors
DART NEUROSCIENCE CAYMAN LTD2 citations61
US9956213B2May 1, 2018
Substituted naphthyridine and quinoline compounds as MAO inhibitors
DART NEUROSCIENCE CAYMAN LTD0 citations50